DW-MRI as a Predictive Biomarker of Radiosensitization of GBM through Targeted Inhibition of Checkpoint Kinases-Reference-Cited by-同舟云学术

DW-MRI as a Predictive Biomarker of Radiosensitization of GBM through Targeted Inhibition of Checkpoint Kinases

Published:2013-04 Issue:2 Volume:6 Page:133-142
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Williams Terence M.,Galbán Stefanie,Li Fei,Heist Kevin A.,Galbán Craig J.,Lawrence Theodore S.,Holland Eric C.,Thomae Tami L.,Chenevert Thomas L.,Rehemtulla Alnawaz,Ross Brian D.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference45 articles.

1. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;Stupp;Lancet Oncol,2009

2. Radiotherapy for glioblastoma in the elderly;Keime-Guibert;N Engl J Med,2007

3. Radiation and new molecular agents part I: targeting ATM-ATR checkpoints, DNA repair, and the proteasome;Choudhury;Semin Radiat Oncol,2006

4. Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A;Sorensen;Cancer Cell,2003

5. Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents;Xiao;JBiol Chem,2003

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perspective on the Use of DNA Repair Inhibitors as a Tool for Imaging and Radionuclide Therapy of Glioblastoma;Cancers;2022-04-03

2. Therapeutic Opportunities of Disrupting Genome Integrity in Adult Diffuse Glioma;Biomedicines;2022-01-31

3. Temozolomide and AZD7762 Induce Synergistic Cytotoxicity Effects on Human Glioma Cells;Anticancer Research;2020-09

4. Preclinical Profiles and Contexts for CHK1 and CHK2 Inhibitors;Cancer Drug Discovery and Development;2018

5. Radiation Changes the Metabolic Profiling of Melanoma Cell Line B16;PLOS ONE;2016-09-15